Patents Assigned to GE Healthcare AS
-
Publication number: 20200199504Abstract: A bioreactor vessel includes a first compartment configured to receive a suspension comprising cells and a cell culture medium, for use in a cell processing operation, a second compartment for receiving an overflow of the cell culture medium from the first compartment, and an overflow separating the first compartment from the second compartment, the overflow being configured to maintain a level of the cell culture medium in the first compartmentType: ApplicationFiled: December 21, 2018Publication date: June 25, 2020Applicant: GE HEALTHCARE BIO-SCIENCES CORP.Inventor: MARK ROBERT TIMMINS
-
Patent number: 10677802Abstract: Methods comprising the use of photoactivated chemical bleaching for detecting multiple targets in a biological sample are provided. The methods include the steps of binding at least one probe to one or more target present in a biological sample including multiple targets, and detecting a signal from the probe. The method further includes the steps of contacting the sample comprising the bound probe with a photoinitiator and irradiating the sample, thereby initiating a photoactivated chemical bleaching process that substantially inactivates the probe. The method further includes the steps of binding at least one probe to one or more target present in the sample, and detecting a signal from the probe. The process of binding, detecting and bleaching may be iteratively repeated.Type: GrantFiled: November 19, 2013Date of Patent: June 9, 2020Assignee: GE Healthcare Bio-Sciences Corp.Inventors: Anup Sood, Arunkumar Natarajan, Lakshmi Sireesha Kaanumalle, Christina Lowes
-
Patent number: 10670569Abstract: Disclosed is a fluid path network (100) comprising plural fluid paths (110) interconnected by plural nodal chambers (120), three or more of said plural paths opening into each of said chambers, and said chambers being adapted the accept a removable fluid path modifying insert (130/140/150 FIGS. 3a-3c). The network is employed in a chromatography system described herein.Type: GrantFiled: June 29, 2016Date of Patent: June 2, 2020Assignee: GE Healthcare Bio-Sciences ABInventor: Bjorn Markus Olovsson
-
Patent number: 10670490Abstract: The present invention relates to a method for a measurement system configured to test a flexible bio-process bag, the method comprising providing at least one flexible bio-process bag having a volume, wherein the at least one flexible bio-process bag is initially filled with a gas and inflated to a reference pressure (Pu), obtaining a leak model, obtaining baseline information, wherein the baseline information comprises at least a weighed first mass value (mbaseline) and a first time value (t1), obtaining evaluation information, wherein the evaluation information comprises at least a weighed second mass value (mevaluation) and a second time value (t2), testing the flexible bio-process bag based on the leak model, the baseline information and the evaluation information.Type: GrantFiled: November 28, 2017Date of Patent: June 2, 2020Assignee: GE Healthcare Bio-Sciences Corp.Inventors: Robert Douglas Burchesky, James Molloy
-
Patent number: 10660966Abstract: A method for removing or controlling or quantifying the presence of aldehydes, in particular acetaldehyde, is described. Such a method is useful in prolonging the shelf life of a pharmaceutical product.Type: GrantFiled: December 4, 2015Date of Patent: May 26, 2020Assignee: GE HEALTHCARE LIMITEDInventors: Torgrim Engell, Julian Grigg, Dimitrios Mantzilas, Dag M. Evje
-
Patent number: 10662261Abstract: The present invention relates to dimeric pentadentate chelators with exceptionally strong binding of metal ions, for detection, immobilization and purification of biomolecules. Dimeric chelators offer a cooperativity of binding of two adjacent immobilized metal ions simultaneously to a histidine-tagged biomolecule, which gives advantageous properties regarding strength of binding compared to a corresponding monomer chelator. In addition, a dimer increases the selectivity (ease of separation) against non-tagged biomolecules with low metal-ion affinity.Type: GrantFiled: March 27, 2018Date of Patent: May 26, 2020Assignee: GE Healthcare BioProcess R&D ABInventors: Mattias Algotsson, Lars C. Andersson, Eggert Brekkan, Lee Hedemyr, Jean-Luc Maloisel, Ronnie Palmgren
-
Patent number: 10663461Abstract: A method of screening a plurality of fluid samples for the presence of species capable of specifically binding to a binding partner immobilized on a sensing surface of a sensor is disclosed. The method comprises contacting each sample with the sensing surface and a reference surface, and subjecting the sensing surface responses obtained for all samples to a computational process which comprises fitting al responses to a model equation for the relationship between a response at the sensing surface and the corresponding response at the reference surface. In an iterative process residuals above a pre-determined threshold value are removed, the model equation is adjusted, and all remaining samples are refitted to the adjusted model equation until the model equation at least substantially converges. Residuals above the predetermined threshold value are considered as species specifically binding to the binding partner.Type: GrantFiled: November 29, 2011Date of Patent: May 26, 2020Assignee: GE HEALTHCARE BIO-SCIENCES ABInventors: Markku Hamalainen, Hakan Roos
-
Patent number: 10658072Abstract: The present invention relates to a method of evaluation of molecular binding interactions at a sensing surface, and more particularly to a method for evaluation of screening data obtained from an interaction between an analyte in a fluid sample and a ligand immobilized on a sensor surface of a biosensor that is independent of interaction models. Preferably the biosensor is a SPR biosensor. The invention also relates to a biosensor system arranged to perform the method and a computer program arranged to control the operation of the biosensor system.Type: GrantFiled: February 9, 2017Date of Patent: May 19, 2020Assignee: GE Healthcare Bio-Sciences ABInventor: Robert Karlsson
-
Patent number: 10654887Abstract: The invention relates to a separation matrix comprising at least 11 mg/ml Fc-binding ligands covalently coupled to a porous support, wherein: a) the ligands comprise multimers of alkali-stabilized Protein A domains, and b) the porous support comprises cross-linked polymer particles having a volume-weighted median diameter (d50,v) of 56-70 micrometers and a dry solids weight of 55-80 mg/ml.Type: GrantFiled: September 30, 2016Date of Patent: May 19, 2020Assignee: GE Healthcare Bio-Process R&D ABInventors: Gustav Jose Rodrigo, Tomas Bjorkman, Mats Ander, Jesper Ulf Hansson
-
Publication number: 20200148987Abstract: A bioreactor vessel includes a body having upper and lowerends and a hollow interior cavity formed in the body, the interior cavity located between the upper and lower ends, the interior cavity being configured to receive biomaterials for processing. The interior cavity includes a lower boundary that is angled toward the lower end of the body such that the vessel may be tilted to allow biomaterials within the interior cavity to be extracted and. concentrated and/or washed without the need for a separate bioprocessing device.Type: ApplicationFiled: November 13, 2018Publication date: May 14, 2020Applicant: GE HEALTHCARE BIO-SCIENCES CORP.Inventors: REGINALD DONOVAN SMITH, Chengkun Zhang, Jason Castle, Kenneth Conway
-
Patent number: 10646600Abstract: A method of use of an isolated polypeptide conjugated with a radionuclide, wherein the isolated polypeptide binds specifically to HER2, or a variant thereof is described. The method is for monitoring the response to HSP90 inhibition and comprises the use of the isolated polypeptide conjugated with 18F. The application also describes the use of an isolated polypeptide conjugated with 18F, wherein the isolated polypeptide binds specifically to HER2 or variants thereof, as an imaging agent to monitor uptake thereof to measure HSP90 inhibition.Type: GrantFiled: June 24, 2014Date of Patent: May 12, 2020Assignees: IMPERIAL INNOVATIONS LIMITED, GE HEALTHCARE LIMITEDInventors: Duncan Robert R. Hiscock, Eric Aboagye, Peter Iveson, Quang-De Nguyen, Susan Hoppmann, Sebastian Trousil, Maciej Kaliszczak, Giampaolo Tomasi
-
Publication number: 20200140805Abstract: Methods, apparatus, systems and articles of manufacture are disclosed herein to implement flexible bioreactor control systems. An example apparatus disclosed herein includes a processor coupled to a memory, the processor programmed to determine whether the map value included in the process task object is a valid map value, the process task object to correspond to a task executed by a bioreactor, a control device or a measurement device of the bioreactor control system configuration, in response to determining the map value is a valid map value, decode the map value to identify the source location of a first input of the process task object, pull a value from the source location to update the input value of the process task object, and facilitate execution of the process task with the input value.Type: ApplicationFiled: November 6, 2019Publication date: May 7, 2020Applicant: GE HEALTHCARE BIO-SCIENCES CORP.Inventor: SCOTT A. MANGIACOTTI
-
Patent number: 10639237Abstract: The present disclosure relates to aseptic connectors with integrated wireless connectivity. For example, an example system may include a removable clamp configured to secure a first portion of an aseptic connector to a second portion of the aseptic connector. The removable clamp may include a housing, a controller disposed within the housing, a rechargeable battery disposed within the housing, a wireless radio disposed within the housing, and a sensor plug receptacle configured to receive a sensor plug coupled to a sensor of the aseptic connector. The controller may be configured to determine a sensor output of the sensor and to transmit the output using the wireless radio.Type: GrantFiled: September 13, 2018Date of Patent: May 5, 2020Assignee: GE HEALTHCARE BIO-SCIENCES CORP.Inventors: Vincent Francis Pizzi, Christopher Dakin McCoy
-
Patent number: 10625210Abstract: A method and a system for improving mixing of content in a container 3 provided in a filter system 1, said method comprising providing a mixing loop 13 parallel to a recirculation flow path 11 of the filter system 1.Type: GrantFiled: October 28, 2016Date of Patent: April 21, 2020Assignee: GE Healthcare Bio-Sciences ABInventors: Klaus Gebauer, Partha Sarathy Doddapadam Srinivasa Raghavachar, Narendra G R, Nachiket Karmarkar, Ajit S. Vernekar, Prashanth Hosabettu Mohan, Sasi Kumar Nutalapati
-
Patent number: 10625095Abstract: A pierce and fill connector cap for a vial sealed by an elastomeric septum includes a vial collar and a needle holder. The vial collar body defines a collar aperture to be positioned in overlying registry with the septum of the vial, and the needle holder includes a needle holder body providing a means for holding an elongate needle in registry with the collar aperture. The needle holder body being moveable with respect to said vial collar between a first position spaced from the vial collar and a second position proximate the vial collar, such that a needle held by the needle holder will puncture through the vial septum.Type: GrantFiled: July 17, 2017Date of Patent: April 21, 2020Assignee: GE HEALTHCARE LIMITEDInventors: Xavier Franci, Philippe Dumont, Svein-Erik Lindgaard
-
Publication number: 20200116678Abstract: A fluid distributor unit comprising a channel system where one or more inlet channels (2) starting on an inlet side (3) of the distributor unit branch out successively into several channels (6) ending on the other side of the distributor unit, called the outlet side (4), characterised in that said distributor unit is provided in one single body (1) by free form fabrication.Type: ApplicationFiled: December 9, 2019Publication date: April 16, 2020Applicant: GE HEALTHCARE BIO-SCIENCES ABInventors: Klaus Gebauer, Jan Kranse, Mats Lundkvist
-
Patent number: 10620172Abstract: The present invention relates to a method for performing liquid chromatography purification of one or more target molecules from a sample comprising: providing an eluent flow having one or more target molecules, measuring an output parameter indicative of the content of the one or more target molecules in the eluent flow, storing output parameter data, and dividing the eluent flow into consecutive eluent fractions, dividing the output parameter data into corresponding data fractions, in each data fraction obtaining a value indicative of characteristic behavior of the measured output parameter, identifying trends in the measured output parameter based upon the obtained value in consecutive data fractions, and identifying peak(s) in the measured output parameter correlated to eluent fractions based upon the identified trends, whereby information of identified peak(s) and correlated eluent fraction(s) can be presented and purified sample(s) from the eluent may be collected.Type: GrantFiled: November 16, 2015Date of Patent: April 14, 2020Assignee: GE Healthcare Bio-Sciences ABInventors: Lena Nyholm, Lotta Hedkvist, Johan Arthursson, Eva Cecilia Olsson, Henrik Larsson
-
Patent number: 10614547Abstract: An adaptive template image for registering a PET or a SPECT image includes a template image model including variability of values for each voxel in a template image according to one or more control parameters.Type: GrantFiled: September 20, 2012Date of Patent: April 7, 2020Assignee: GE HEALTHCARE LIMITEDInventors: Roger Lundqvist, Nils Lennart Thurfjell, Johan Lilja
-
Patent number: D886994Type: GrantFiled: December 20, 2017Date of Patent: June 9, 2020Assignee: GE HEALTHCARE BIO-SCIENCES ABInventors: Mats Lundkvist, Bjorn A. Johansson, Tim Francois
-
Patent number: D886995Type: GrantFiled: December 20, 2017Date of Patent: June 9, 2020Assignee: GE HEALTHCARE BIO-SCIENCES ABInventors: Mats Lundkvist, Bjorn A. Johansson, Tim Francois